Last updated on November 2017

A Phase II, Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)


Brief description of study

A Phase II, Multi-Center, Single-Arm, Global Study of MEDI4736 Monotherapy in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Detailed Study Description

To assess the efficacy of MEDI4736 monotherapy in terms of ORR.

Clinical Study Identifier: TX7407

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Holy Cross Hospital

Holy Cross Hospital
Fort Lauderdale, FL USA
  Connect »